普昂医疗
(920069)
| 流通市值：5.39亿 | | | 总市值：19.31亿 |
| 流通股本：1477.77万 | | | 总股本：5291.40万 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 99,307,104.37 | 382,193,622.56 | 277,345,335.6 | 178,343,387.97 |
| 营业收入 | 99,307,104.37 | 382,193,622.56 | 277,345,335.6 | 178,343,387.97 |
| 二、营业总成本 | 73,165,861.63 | 286,279,519.41 | 202,909,860.21 | 129,706,507.57 |
| 营业成本 | 45,657,809.58 | 183,325,700.62 | 131,794,245.06 | 84,704,227.3 |
| 税金及附加 | 1,613,091.55 | 7,213,468.92 | 5,483,747.37 | 2,853,612.88 |
| 销售费用 | 11,672,865.47 | 42,742,836.72 | 28,994,286.63 | 19,087,592.95 |
| 管理费用 | 7,890,040.31 | 32,106,939.03 | 22,629,881.44 | 14,871,153.36 |
| 研发费用 | 4,625,504.98 | 21,152,137.22 | 14,941,160.69 | 9,505,000.48 |
| 财务费用 | 1,706,549.74 | -261,563.1 | -933,460.98 | -1,315,079.4 |
| 其中:利息费用 | 62,103.64 | 502,418.99 | 501,260.57 | 441,597.97 |
| 其中:利息收入 | 69,805.78 | 272,579.62 | 180,420.33 | 85,789.02 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | - | -52.38 | - | - |
| 资产处置收益 | -51,040.72 | -27,650.17 | -27,650.17 | -2,383.16 |
| 资产减值损失(新) | -582,916.65 | -2,419,735.14 | -969,882.09 | -917,377.48 |
| 信用减值损失(新) | 375,128.63 | -895,319.79 | -130,507.18 | -689,164.45 |
| 其他收益 | 1,934,101.64 | 12,280,132.72 | 9,184,756.96 | 5,902,261.38 |
| 四、营业利润 | 27,816,515.64 | 104,851,478.39 | 82,492,192.91 | 52,930,216.69 |
| 加:营业外收入 | 15,576.14 | 114,456.8 | 94,081.67 | 55,415.26 |
| 减:营业外支出 | 46,323.05 | 1,527,878.03 | 1,294,644.67 | 1,263,505.16 |
| 五、利润总额 | 27,785,768.73 | 103,438,057.16 | 81,291,629.91 | 51,722,126.79 |
| 减:所得税费用 | 4,121,548.24 | 13,662,271.54 | 11,475,804.28 | 7,392,179.8 |
| 六、净利润 | 23,664,220.49 | 89,775,785.62 | 69,815,825.63 | 44,329,946.99 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 23,664,220.49 | 89,775,785.62 | 69,815,825.63 | 44,329,946.99 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 23,664,220.49 | 89,775,785.62 | 69,815,825.63 | 44,329,946.99 |
| 扣除非经常损益后的净利润 | 23,287,991.38 | 84,502,909.58 | 65,720,170.09 | 43,079,146.99 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.56 | 2.12 | 1.65 | 1.05 |
| (二)稀释每股收益 | 0.56 | 2.12 | 1.65 | 1.05 |
| 九、综合收益总额 | 23,664,220.49 | 89,775,785.62 | 69,815,825.63 | 44,329,946.99 |
| 归属于母公司股东的综合收益总额 | 23,664,220.49 | 89,775,785.62 | 69,815,825.63 | 44,329,946.99 |
| 公告日期 | 2026-04-23 | 2026-02-05 | 2025-12-12 | 2025-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | 标准无保留意见 |